Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

618.46
1,323,173

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

After-Market: $618.47 +0.01 (0.00%) 5:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Daniel Laboe headshot

Buyers Come In With A Penchant For Growth After Short Market Correction

This week's riveting earnings line-up promises to be chalked full of enlightening quarterly reports from leading corporations across sectors

Why Thermo Fisher (TMO) Might Surprise This Earnings Season

Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates

ResMed's (RMD) Q2 earnings meet estimates, with robust demand for sleep and respiratory care devices driving the top line.

Nalak Das headshot

5 Corporate Giants Likely to Gain From Q4 Earnings Next Week

Five corporate behemoths will report fourth-quarter 2021 earnings results next week. These are: TMO, FB, GOOGL, GILD and UPS.

Thermo Fisher (TMO) Base Sales Rebound, Bioproduction in Focus

Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used in the mRNA manufacturing process.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

Thermo Fisher Scientific (TMO) closed at $562.90 in the latest trading session, marking a -0.85% move from the prior day.

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: Microsoft, Visa, Cisco, Berkshire Hathaway and Thermo Fisher Scientific

Microsoft, Visa, Cisco, Berkshire Hathaway and Thermo Fisher Scientific are included in this analyst blog.

Rise in COVID Tests to Boost Thermo Fisher (TMO) Q4 Earnings

With the emergence of the Omicron variant through the Q4 months globally, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered strong top-line contributions.

Sheraz Mian headshot

Top Research Reports for Microsoft, Visa & Cisco

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Visa Inc. (V), and Cisco Systems, Inc. (CSCO).

Thermo Fisher Scientific (TMO) Stock Moves -0.88%: What You Should Know

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $588.16, marking a -0.88% move from the previous day.

Here's Why You Should Retain Thermo Fisher (TMO) Stock for Now

Investors are optimistic about Thermo Fisher's (TMO) strong end-market growth and focus on international regions.

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $625.20, moving +0.76% from the previous trading session.

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Thermo Fisher (TMO) Completes Buyout of PeproTech for $1.85B

Thermo Fisher's (TMO) recent acquisition will boost its capabilities to serve in the high-growth cell and gene therapy market.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $620.40, moving +0.3% from the previous trading session.

Hologic's (HOLX) GAI Program to Include Aptima SARS-CoV-2 Assay

The addition of Aptima SARS-CoV-2 assay to Hologic's (HOLX) Global Access Initiative is likely to improve its accessibility.

Here's Why You Should Retain Stryker (SYK) Stock Right Now

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure remains a concern.

PacBio (PACB) Ties Up to Boost Rare Disease Diagnosis in Canada

PacBio's (PACB) recent partnership with Care4Rare, with regard to a study, has the potential to enhance rare disease diagnosis within Canada.

Debanjana Dey headshot

4 Stocks to Watch Out For as MedTech Rides on Buyout Frenzy

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

STERIS (STE) Hits a New 52-Week High: What's Driving It?

Strong segmental performances are driving the top line for STERIS (STE).

3 Reasons to Retain Integer Holdings (ITGR) Stock For Now

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio. However, contraction in gross margin is a woe.

Nevro's (NVRO) 10 kHz Therapy for Treatment of PDN Gets Coverage

Nevro (NVRO) receives coverage for its high-frequency 10 kHz therapy for the treatment of PDN.